Get the app
Healthcare2 min reading time

Red Queen Bio is using AI to design antibodies for future viruses, WSJ says

The Next Web
Read the full article
Red Queen Bio, backed by OpenAI, has raised $36M to develop AI-designed antibody drugs targeting viruses like bird flu, with clinical trials planned for 2027. The startup aims to rapidly scale biological defenses against future viral threats, including those potentially engineered by AI.

More on this story

#biosecurity#google-deepmind#hannu-rajaniemi#nikolai-eroshenko#openai#red-queen-bio

More in Healthcare

Healthcare32 min read

Development of an automated method for audiometric data extraction and analysis using voting optical character recognition

Nature
Healthcare3 min read

Microsoft Says Its New AI Is Better at Diagnosing Patients Than Real Doctors

Futurism
Healthcare2 min read

UK government sets out $800 million for AI security funding

ET AI (The Economic Times)